Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED BALANCE SHEETS

v3.6.0.2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2016
Dec. 31, 2015
Jun. 30, 2015
Current assets      
Cash and cash equivalents $ 158,779 $ 194,263 $ 229,046
Short-term deposits 22,694 54,620 55,292
Accounts receivable, net of allowance for doubtful accounts of $-, $- and $- (including amounts due from related parties of $-, $2 and $3) 1,480 744 4
Other current assets and prepaid expenses (including current portion of clinical materials) 15,798 13,420 10,740
Total current assets 198,751 263,047 295,082
Restricted cash 4,017 4,508  
Clinical materials 2,580 4,736  
Property, plant and equipment, net 27,899 13,225 5,393
Intangibles, net 1,268 305 178
Total assets 234,515 285,821 300,653
Current liabilities      
Accounts payable (including amounts due to related parties of $326, $- and $143) 11,350 7,884 1,982
Accrued expenses and other accrued liabilities (including amounts due to related parties of $39, $288 and $2) 17,528 7,518 3,877
Deferred revenue 11,392 12,487 20,906
Total current liabilities 40,270 27,889 26,765
Deferred revenue, non-current 24,962 22,939 14,885
Accrued expenses, non-current 3,141    
Total liabilities 68,373 50,828 41,650
Contingencies and commitments - Note 8
Stockholders' Equity      
Common stock - Ordinary shares par value GBP 0.001, 574,711,900 authorized and 424,775,092 issued and outstanding (December 31, 2015 and June 30, 2015: 574,711,900 authorized and 424,711,900 issued and outstanding) 683 682 682
Additional paid in capital 341,200 332,363 328,795
Accumulated other comprehensive loss (14,249) (8,139) (3,561)
Accumulated deficit (161,492) (89,913) (66,913)
Total stockholders' equity 166,142 234,993 259,003
Total liabilities and stockholders' equity $ 234,515 $ 285,821 $ 300,653